产品封面图
文献支持

SARS-CoV-2 RBD Neutralizing 抗体

[7V816]-SARS-CoV-2 RBD Neutralizing Antibody [7V816]
收藏
  • ¥22
  • ProSci已认证
  • 美国
  • PSI-11-088-0.1mg
  • 2025年07月13日
  • E
  • 小鼠
avatar
代理商
13皇冠会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 免疫原

      HEK293 derived SARS-COV-2 SPIKE RBD, amino acids Arg319-Phe541

    • 保存条件

      stored at 2℃ to -8℃ for one month without detectable loss of activity

    • 保质期

      1年

    • 级别

      科研级别

    • 库存

      100

    • 供应商

      艾美捷科技

    • 宿主

      小鼠

    • 应用范围

      E

    • 抗体英文名

      SARS-CoV-2 RBD Neutralizing Antibody [7V816]

    • 抗体名

      SARS-CoV-2 RBD Neutralizing Antibody [7V816]

    • 规格

      0.1mg

    SARS-CoV-2 RBD Neutralizing 抗体 [7V816],SARS-CoV-2 RBD Neutralizing Antibody [7V816],SARS-CoV-2 RBD Neutralizing 抗体 [7V816],SARS-CoV-2 RBD Neutralizing Antibody [7V816]

    产品名称:SARS-CoV-2 RBD Neutralizing 抗体 [7V816]-SARS-CoV-2 RBD Neutralizing Antibody [7V816]

    产品货号:PSI-11-088-0.1mg

    产品规格:0.1mg

    背景资料:The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell. The spike is essential for both host specificity and viral infectivity. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. It''s been reported that SARS-CoV-2 (COVID-19 coronavirus, 2019-nCoV) can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. The main functions for the Spike protein are summarized as: Mediate receptor binding and membrane fusion; Defines the range of the hosts and specificity of the virus; Main component to bind with the neutralizing antibody; Key target for vaccine design; Can be transmitted between different hosts through gene recombination or mutation of the receptor binding domain (RBD), leading to a higher mortality rate

    艾美捷科技

    保存建议:SARS-CoV-2 RBD Neutralizing 抗体 [7V816]-SARS-CoV-2 RBD Neutralizing Antibody [7V816] stored at 2℃ to -8℃ for one month without detectable loss of activity

    应用类型:E

    点击:SARS-CoV-2 RBD Neutralizing 抗体 [7V816]-SARS-CoV-2 RBD Neutralizing Antibody [7V816]查看更详细产品说明,更多应用、储存、价格、货期等信息请垂询艾美捷科技有限公司。更多ProSci公司特色试剂盒、特色抗体以及特色试剂等产品评论,请点击查看艾美捷特色产品中心。

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    SARS-CoV-2 RBD Neutralizing Antibody [7V816]
    相关实验
    • 中科院高福院士课题组 2020 年发表了哪些重要的研究成果?

      :Science 9、Science 后再发 Nature!筛选出又一新冠病毒治疗性单克隆中和抗体DOI: 10.1038/s41586-020-2381-y继之前发表在 Science 上报道筛选出新冠病毒中和抗体后,2020 年 5 月 26 日,高福院士再次联合严景华等人在 Nature 发文:A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2。该研究报告了从 COVID-19 恢复期的患者中分离出两

    • 聊一聊血清学研究中的表面封闭剂

      neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Preprint at bioRxiv 11: Lynch, KL et al. (2020) Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity. Preprint

    • XBB.1.5 毒株的传播力为何这么强?北大曹云龙团队最新研究揭示相关机制

      1 月 3 日,北京大学曹云龙团队及其合作者在预印本平台 bioRxiv,发表了题为 Enhanced transmissibility of XBB.1.5 is contributed by both strong ACE2 binding and antibody evasion 的文章,报道了关于 XBB.1.5 的最新研究成果。该研究表明,XBB.1.5 的传播性增强是由与 ACE2 的强结合和抗体逃逸共同促成的,该团队此前开发的中和抗体 SA55 对 XBB.1.5 仍有很强的活性

    图标技术资料

    暂无技术资料 索取技术资料

    文献支持
    SARS-CoV-2 RBD Neutralizing 抗体 [7V816]-SARS-CoV-2 RBD Neutralizing Antibody [7V816]
    ¥22